News Center

Scaling Up Science During a Global-Scale Emergency

Our biomanufacturing experts are helping accelerate the development of new COVID-19-fighting technologies. Learn how the scientists at the ABPDU are collaborating with biotech companies to scale up and optimize production of coronavirus-targeting antibodies and a highly accurate rapid testing system.

VIDEOS: Science Collaborations Find a Way During COVID-19 Pandemic

Even an underground experiment 4,600 feet below a mountain in Central Italy, and a telescope instrument more than a mile high atop an Arizona mountaintop could not escape the impacts of the COVID-19 pandemic. In these videos, a Berkeley Lab scientist and two Berkeley Lab-affiliated researchers share their experiences of working in international collaborations during the COVID-19 pandemic.

This Enigmatic Protein Sculpts DNA to Repair Harmful Damage

Sometimes, when something is broken, the first step to fixing it is to break it even more. Scientists have discovered this is the case for a human DNA repair protein that functions by marking and then further breaking damaged DNA. Their surprising findings have provided much-needed insight into how DNA repair works in healthy cells, as well as how different mutations can translate into different diseases and cancer.

Using Machine Learning to Estimate COVID-19’s Seasonal Cycle

One of the many unanswered scientific questions about COVID-19 is whether it is seasonal like the flu – waning in warm summer months then resurging in the fall and winter. Now scientists at Lawrence Berkeley National Laboratory are launching a project to apply machine-learning methods to a plethora of health and environmental datasets, combined with high-resolution climate models and seasonal forecasts, to tease out the answer.

X-ray Experiments Zero in on COVID-19 Antibodies

An international scientific team has discovered a neutralizing antibody, derived from the blood of a SARS survivor, that inhibits the closely related COVID-19-causing coronavirus. In a paper published this week in Nature, the scientists note that the antibody is already on an accelerated development path toward clinical trials.

New Research Launched on Airborne Virus Transmission in Buildings

As society prepares to reopen indoor spaces and ease back into some sense of normalcy during the COVID-19 pandemic, a team of researchers at Berkeley Lab is launching a study of the risk of airborne transmission of viruses within buildings and how to mitigate those risks.

Scientists Explore Links Between Genetics, Gut Microbiome, and Memory

Scientists from Pacific Northwest and Lawrence Berkeley National Laboratories showed that both dietary and supplementary sources of a common gut microbe or its main chemical product, lactic acid, led to better memory performance in mice.

Staff at Berkeley Lab’s X-Ray Facility Mobilize to Support COVID-19-Related Research

Berkeley Lab’s Advanced Light Source X-ray facility has been recalled to action to support research related to COVID-19, the coronavirus disease that has already infected about 2 million people around the world.

Rare Disease Q&A: What Rare Diseases Are and Why That Matters

Berkeley Lab’s Chris Mungall and Nomi Harris explain how agreeing on precise definitions of each rare disease can lead to more accurate diagnoses and better treatments, and share new evidence showing this endeavor is more important than ever.

A Matchmaker for Microbiomes

A unique neural network tool is making it possible to accurately infer the interactions between the microbes that are present in a community and the metabolites they produce – a capability that will greatly advance research into the microbiomes in the environment and inside our bodies.